Auna Reports 6% Revenue Growth in Q4
- Revenue Growth: Auna's Q4 revenue increased by 7% year-over-year to S/1.133 billion, indicating sustained commercial momentum in its core markets despite economic challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to S/220 million, down 14% year-over-year, with the EBITDA margin decreasing to 19.5%, reflecting pressures from cost management and intensified market competition.
- Significant Net Income Improvement: Adjusted net income rose sharply from S/36 million in the previous year to S/136 million, indicating a notable enhancement in profitability that may boost investor confidence.
- Future Outlook: Auna projects approximately 12% revenue growth for fiscal year 2026, with similar EBITDA growth expectations, showcasing the company's confidence in future growth driven by ongoing commercial execution and disciplined cost management.
Trade with 70% Backtested Accuracy
Analyst Views on AUNA
About AUNA
About the author
Auna S.A. Reports Q1 2026 Operating Metrics
- Emergency Treatment Volume Growth: In Q1 2026, Auna reported 7,864 emergency treatments in Mexico, a slight decrease from 8,002 in Q4 2025, yet indicating stable service demand and the company's ongoing influence in healthcare services.
- Surgery Numbers Increase: In Peru, surgeries reached 5,851 in Q1 2026, a significant rise from 4,973 in Q4 2025, demonstrating Auna's enhanced surgical capabilities, which are crucial for increasing market share.
- Stable Hospitalization Days: Auna recorded 80,716 hospitalization days in Colombia for Q1 2026, up from 79,349 in Q4 2025, reflecting improved bed utilization and further solidifying its market position in the region.
- Membership Growth: As of Q1 2026, Auna's plan memberships reached 1,439,781, an increase from 1,424,695 in Q4 2025, showcasing the effectiveness of the company's expansion strategy in the Latin American market and strengthening its customer base.
Auna S.A. Q4 2025 Earnings Call Insights
- Significant Revenue Growth: Auna's consolidated revenue grew 6% year-over-year in Q4 2025, reaching PEN 220 million, although adjusted EBITDA declined 14% due to underperformance in Mexico, highlighting the company's resilience and challenges in diverse markets.
- Substantial Net Income Increase: The company's adjusted net income for Q4 reached PEN 136 million, a significant rise from PEN 36 million in the same quarter last year, with full-year net income more than tripling to PEN 336 million, reflecting successful capital structure optimization and cost management.
- Optimistic Future Outlook: Management expects adjusted EBITDA to increase by 12% in 2026, with capital expenditures projected to remain at approximately 4% of revenue, indicating strong confidence in the recovery of the Mexican market and overall growth strategy.
- Strategic Investments and Risk Management: Auna's operational stability in Mexico has improved, with new contracts like ISSSTELEON set to expand market coverage, although management cautioned about potential risks from macroeconomic conditions and payor dynamics.
Auna Reports 6% Revenue Growth in Q4
- Revenue Growth: Auna's Q4 revenue increased by 7% year-over-year to S/1.133 billion, indicating sustained commercial momentum in its core markets despite economic challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to S/220 million, down 14% year-over-year, with the EBITDA margin decreasing to 19.5%, reflecting pressures from cost management and intensified market competition.
- Significant Net Income Improvement: Adjusted net income rose sharply from S/36 million in the previous year to S/136 million, indicating a notable enhancement in profitability that may boost investor confidence.
- Future Outlook: Auna projects approximately 12% revenue growth for fiscal year 2026, with similar EBITDA growth expectations, showcasing the company's confidence in future growth driven by ongoing commercial execution and disciplined cost management.
Auna S.A. Announces 2025 Financial Results Dates
- Earnings Release Schedule: Auna S.A. is set to report its Fourth Quarter and Full-Year 2025 financial results on March 10, 2026, after market close, which is expected to provide investors with critical performance data to assess the company's future growth potential.
- Conference Call Timing: The company will hold a conference call on March 11, 2026, at 8:00 a.m. ET to provide a detailed interpretation of the financial results and answer investor questions, thereby enhancing transparency and investor confidence.
- Quiet Period Details: Auna will enter a quiet period from February 23 to March 10, 2026, during which no public discussions related to financial performance will occur, ensuring compliance and fairness in information disclosure.
- Company Background: Auna is a leading healthcare services and plan provider in Latin America, focusing on high-complexity diseases, with a network of 31 healthcare facilities and 2,333 beds, serving 1.4 million healthcare plans, showcasing its strong integration capabilities in the Spanish-speaking markets.
EsSalud Receives Construction License for Torre Trecca, Signifying Important Milestone in Auna's Public-Private Partnership with the Organization
Construction License Received: Auna S.A. has received a construction license for Torre Trecca, a high-rise outpatient treatment center in Lima, Peru, which will serve over six million EsSalud-insured Peruvians.
Public-Private Partnership: The project is part of a public-private partnership with EsSalud, initiated in 2010, aimed at modernizing healthcare services in the region.
Expected Impact: Once completed, Torre Trecca is projected to accommodate more than three million visits annually, significantly enhancing healthcare access in Lima.
Forward-Looking Statements: Auna's announcement includes forward-looking statements regarding the project's timeline and capacity, emphasizing potential risks and uncertainties that may affect outcomes.
Auna Finalizes $765 Million Debt Refinancing Deal
Debt Refinancing Announcement: Auna S.A. successfully closed a US$765 million debt refinancing, which includes the issuance of US$365 million in Senior Secured Notes due 2032 and a US$400 million Term Loan, aimed at extending debt maturities and improving liquidity.
Financial Improvements: The refinancing lowers interest expenses and extends the average maturity of Auna's debt, contributing to a target leverage ratio of 3x Net Debt-to-EBITDA, improving from 4.5x at year-end 2023.
Investor Confidence: The transaction received a B+ rating from S&P and Fitch, highlighting its positive impact on Auna's liquidity ratios and short-term debt maturities, and reflects strong support from major banks and institutional investors, including the International Finance Corporation.
Auna's Mission and Operations: Auna is a leading healthcare provider in Latin America, focusing on integrated healthcare services and complex diseases, with a network of 31 facilities and over 1.4 million health plan members as of June 30, 2025.
Auna S.A. Reports Q1 2026 Operating Metrics
- Emergency Treatment Volume Growth: In Q1 2026, Auna reported 7,864 emergency treatments in Mexico, a slight decrease from 8,002 in Q4 2025, yet indicating stable service demand and the company's ongoing influence in healthcare services.
- Surgery Numbers Increase: In Peru, surgeries reached 5,851 in Q1 2026, a significant rise from 4,973 in Q4 2025, demonstrating Auna's enhanced surgical capabilities, which are crucial for increasing market share.
- Stable Hospitalization Days: Auna recorded 80,716 hospitalization days in Colombia for Q1 2026, up from 79,349 in Q4 2025, reflecting improved bed utilization and further solidifying its market position in the region.
- Membership Growth: As of Q1 2026, Auna's plan memberships reached 1,439,781, an increase from 1,424,695 in Q4 2025, showcasing the effectiveness of the company's expansion strategy in the Latin American market and strengthening its customer base.
Auna S.A. Q4 2025 Earnings Call Insights
- Significant Revenue Growth: Auna's consolidated revenue grew 6% year-over-year in Q4 2025, reaching PEN 220 million, although adjusted EBITDA declined 14% due to underperformance in Mexico, highlighting the company's resilience and challenges in diverse markets.
- Substantial Net Income Increase: The company's adjusted net income for Q4 reached PEN 136 million, a significant rise from PEN 36 million in the same quarter last year, with full-year net income more than tripling to PEN 336 million, reflecting successful capital structure optimization and cost management.
- Optimistic Future Outlook: Management expects adjusted EBITDA to increase by 12% in 2026, with capital expenditures projected to remain at approximately 4% of revenue, indicating strong confidence in the recovery of the Mexican market and overall growth strategy.
- Strategic Investments and Risk Management: Auna's operational stability in Mexico has improved, with new contracts like ISSSTELEON set to expand market coverage, although management cautioned about potential risks from macroeconomic conditions and payor dynamics.
Auna Reports 6% Revenue Growth in Q4
- Revenue Growth: Auna's Q4 revenue increased by 7% year-over-year to S/1.133 billion, indicating sustained commercial momentum in its core markets despite economic challenges.
- Adjusted EBITDA Decline: Adjusted EBITDA fell to S/220 million, down 14% year-over-year, with the EBITDA margin decreasing to 19.5%, reflecting pressures from cost management and intensified market competition.
- Significant Net Income Improvement: Adjusted net income rose sharply from S/36 million in the previous year to S/136 million, indicating a notable enhancement in profitability that may boost investor confidence.
- Future Outlook: Auna projects approximately 12% revenue growth for fiscal year 2026, with similar EBITDA growth expectations, showcasing the company's confidence in future growth driven by ongoing commercial execution and disciplined cost management.
Auna S.A. Announces 2025 Financial Results Dates
- Earnings Release Schedule: Auna S.A. is set to report its Fourth Quarter and Full-Year 2025 financial results on March 10, 2026, after market close, which is expected to provide investors with critical performance data to assess the company's future growth potential.
- Conference Call Timing: The company will hold a conference call on March 11, 2026, at 8:00 a.m. ET to provide a detailed interpretation of the financial results and answer investor questions, thereby enhancing transparency and investor confidence.
- Quiet Period Details: Auna will enter a quiet period from February 23 to March 10, 2026, during which no public discussions related to financial performance will occur, ensuring compliance and fairness in information disclosure.
- Company Background: Auna is a leading healthcare services and plan provider in Latin America, focusing on high-complexity diseases, with a network of 31 healthcare facilities and 2,333 beds, serving 1.4 million healthcare plans, showcasing its strong integration capabilities in the Spanish-speaking markets.
EsSalud Receives Construction License for Torre Trecca, Signifying Important Milestone in Auna's Public-Private Partnership with the Organization
Construction License Received: Auna S.A. has received a construction license for Torre Trecca, a high-rise outpatient treatment center in Lima, Peru, which will serve over six million EsSalud-insured Peruvians.
Public-Private Partnership: The project is part of a public-private partnership with EsSalud, initiated in 2010, aimed at modernizing healthcare services in the region.
Expected Impact: Once completed, Torre Trecca is projected to accommodate more than three million visits annually, significantly enhancing healthcare access in Lima.
Forward-Looking Statements: Auna's announcement includes forward-looking statements regarding the project's timeline and capacity, emphasizing potential risks and uncertainties that may affect outcomes.
Auna Finalizes $765 Million Debt Refinancing Deal
Debt Refinancing Announcement: Auna S.A. successfully closed a US$765 million debt refinancing, which includes the issuance of US$365 million in Senior Secured Notes due 2032 and a US$400 million Term Loan, aimed at extending debt maturities and improving liquidity.
Financial Improvements: The refinancing lowers interest expenses and extends the average maturity of Auna's debt, contributing to a target leverage ratio of 3x Net Debt-to-EBITDA, improving from 4.5x at year-end 2023.
Investor Confidence: The transaction received a B+ rating from S&P and Fitch, highlighting its positive impact on Auna's liquidity ratios and short-term debt maturities, and reflects strong support from major banks and institutional investors, including the International Finance Corporation.
Auna's Mission and Operations: Auna is a leading healthcare provider in Latin America, focusing on integrated healthcare services and complex diseases, with a network of 31 facilities and over 1.4 million health plan members as of June 30, 2025.
